What is the typical dosage of Cephalexin for treating bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin Dosing for Bacterial Infections

For adults with skin and soft tissue infections, cephalexin 500 mg four times daily is the standard dose, while pediatric patients require 25-50 mg/kg/day divided into four doses. 1

Adult Dosing

The FDA-approved adult dosage ranges from 1 to 4 grams daily in divided doses. 1

Standard Regimens by Indication:

  • Skin and soft tissue infections (MSSA): 500 mg four times daily (QID) 2, 1
  • Streptococcal pharyngitis: 500 mg every 12 hours 1
  • Uncomplicated cystitis (patients >15 years): 500 mg every 12 hours for 7-14 days 1
  • Routine infections: 250 mg every 6 hours 1

For more severe infections or less susceptible organisms, larger doses may be needed, but if daily doses exceed 4 grams, parenteral cephalosporins should be considered. 1

Recent Evidence on Dosing Frequency:

A 2023 study demonstrated that cephalexin 500 mg twice daily is as effective as four-times-daily dosing for uncomplicated urinary tract infections, with no difference in treatment failure rates (12.7% vs 17%, P=0.343) and may improve patient adherence. 3 However, this applies specifically to UTIs, not other infections.

Pediatric Dosing

The usual recommended daily dosage for pediatric patients is 25-50 mg/kg/day in divided doses. 1

Age-Specific Considerations:

  • Infants 29-60 days old with UTI: 50-100 mg/kg/day divided into 4 doses 2
  • Streptococcal pharyngitis and skin infections (>1 year): Total daily dose may be divided every 12 hours 1
  • Otitis media: 75-100 mg/kg/day in 4 divided doses is required 1
  • Severe infections: Dosage may be doubled 1

For β-hemolytic streptococcal infections, therapeutic dosage must be administered for at least 10 days. 1

Duration of Therapy

The typical treatment duration for uncomplicated skin infections is 7 days, depending on clinical response. 4 If the infection has not improved within 5 days, treatment should be extended. 4

Critical Limitations and Pitfalls

MRSA Coverage:

Cephalexin is NOT effective against MRSA; if MRSA is suspected or confirmed, alternative agents (vancomycin, linezolid, clindamycin, or daptomycin) must be used. 2, 4 This is a common prescribing error that can lead to treatment failure.

Limited Pathogen Coverage:

  • Cephalexin has limited activity against Pasteurella multocida and anaerobes, making it inappropriate for animal bites without additional coverage. 4
  • For Haemophilus influenzae infections, cephalexin fails in approximately 50% of cases, particularly in otitis media. 5

Penicillin Allergy:

Patients with immediate hypersensitivity reactions to penicillin should use cephalexin cautiously due to potential cross-reactivity. 2, 4 However, for non-immediate reactions, cephalexin is an acceptable alternative. 2

Renal Dosing Adjustments

Patients with creatinine clearance <30 mL/min require dosage reduction proportional to their reduced renal function. 6 Cephalexin is 70-100% renally excreted within 6-8 hours. 6

Clinical Pharmacology

Cephalexin achieves urinary concentrations of 500-1000 mcg/mL following 250-500 mg oral doses, far exceeding the minimum inhibitory concentration for typical urinary pathogens. 6 It is rapidly and completely absorbed in the upper intestine, with minimal gastrointestinal disturbance since it does not affect lower bowel flora. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cephalexin Dosing for Skin Abrasion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.